Lazard related stories
All articles and analysis
Side Letter: A $20bn CV?Industry participants reckon continuation fund sizes could hit double digits by the end of the decade. Plus: why GPs should be wary of customs costs under the Trump administration. Here's today's brief, for our valued subscribers only.
Lazard secondaries head sees record-breaking wave of dealflow in Q1LPs and GPs alike are finding secondaries technology 'extremely beneficial', Holcombe Green said at PEI Group's NEXUS 2025 conference in Orlando this week.
Key trends: GP-leds poised for further growth after clearing fundraising milestoneGP-led secondaries had a strong 2024, setting new records in some areas. With ample dry powder and rising demand, 2025 looks promising. But will fundraising challenges and regulatory uncertainties dampen growth?
Side Letter: Blue Owl's boss lossA founding partner of Blue Owl's GP stakes business has left while it raises a new fund. Plus: why an ex-Monument team are launching their new shop from a position of strength; and a look at which secondaries strategy boasts the strongest DPI. Here's today's brief, for our valued subscribers only.
Lazard loses APAC rainmaker KimisPEI named David Kimis in its 2018 ranking of the world’s most influential fundraisers.
Secondaries Awards 2024: EMEA winnersColler Capital misses out on Secondaries Firm of the Year in EMEA to Ardian, which completed deals worth more than $15 billion in total across the US and Europe during the judging period.
Secondaries Awards 2024: Asia-Pacific winnersThe top secondaries deals, firms, law firms and advisers of the year from the APAC region.
Side Letter: LACERS' performance envyLACERS believes private markets could cure what ails its underwhelming returns. Plus: Secondaries musical chairs continue apace with a Jefferies to Moelis move; and Carlyle has a new APAC wealth head. Here's today's brief, for our valued subscribers only.
Side Letter: Private wealth pricing powerPrivate wealth's love affair with secondaries is expected to impact pricing in 2025. Plus: Blue Owl is tapping Japanese HNWIs; and GP stakes firm Hunter Point has a new APAC fundraising head. Here's today's brief, for our valued subscribers only.
Secondaries volume to maintain strong pace on back of expected record yearSecondaries professionals and LPs dust off their crystal balls to give their views on what will drive the market over the next 12 months.